ENO2 and myeloid sarcoma: Moreover, potential CSF biomarkers related to the pathomechanism of MS include markers of demyelination (MBP—myelin basic protein, MBP-LM, anti-MBP, anty-MOG, anti-PLP), glial activation (S100b, GFAP), axonal damage (Tau protein, NF, NSE—Neuron-Specific Enolase, NAA—N-acetylaspartate, 14-3-3), and inflammation (CXCL13, IFN-λ, TNF-α, TNF-β, neopterin, soluble CD14, IL-2, IL-2R, IL-6, IL-10) [7,8].